Recent Finacing
Recent Raise
Chase Pharmaceuticals is a Washington, D.C.–based early-stage drug developer focused on Alzheimer’s therapies, advancing oral CPC-201 (Phase 2) and transdermal CPC-252 using a patented efficacy/safety-enhancing approach.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors